首页> 外文期刊>BMC Genomics >Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesothelioma
【24h】

Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesothelioma

机译:在多个人类肿瘤基因表达数据集中对衰老信号进行评分,在NCI60面板中鉴定衰老评分与药物毒性之间的相关性以及与腹膜间皮瘤生存优势相关的促炎信号

获取原文
           

摘要

Background Cellular senescence is a major barrier to tumour progression, though its role in pathogenesis of cancer and other diseases is poorly understood in vivo. Improved understanding of the degree to which latent senescence signalling persists in tumours might identify intervention strategies to provoke "accelerated senescence" responses as a therapeutic outcome. Senescence involves convergence of multiple pathways and requires ongoing dynamic signalling throughout its establishment and maintenance. Recent discovery of several new markers allows for an expression profiling approach to study specific senescence phenotypes in relevant tissue samples. We adopted a "senescence scoring" methodology based on expression profiles of multiple senescence markers to examine the degree to which signals of damage-associated or secretory senescence persist in various human tumours. Results We first show that scoring captures differential induction of damage or inflammatory pathways in a series of public datasets involving radiotherapy of colon adenocarcinoma, chemotherapy of breast cancer cells, replicative senescence of mesenchymal stem cells, and progression of melanoma. We extended these results to investigate correlations between senescence score and growth inhibition in response to ~1500 compounds in the NCI60 panel. Scoring of our own mesenchymal tumour dataset highlighted differential expression of secretory signalling pathways between distinct subgroups of MPNST, liposarcomas and peritoneal mesothelioma. Furthermore, a pro-inflammatory signature yielded by hierarchical clustering of secretory markers showed prognostic significance in mesothelioma. Conclusions We find that "senescence scoring" accurately reports senescence signalling in a variety of situations where senescence would be expected to occur and highlights differential expression of damage associated and secretory senescence pathways in a context-dependent manner.
机译:背景细胞衰老是肿瘤进展的主要障碍,尽管在体内对它在癌症和其他疾病的发病机理中的作用了解甚少。对潜在衰老信号在肿瘤中持续存在的程度的更好理解可能会确定干预策略,以激发“加速衰老”反应作为治疗结果。衰老涉及多种途径的融合,并且在其建立和维护过程中需要不断的动态信号传递。最近发现了几种新的标记物,使得表达谱分析方法能够研究相关组织样品中的特定衰老表型。我们采用了基于多个衰老标记物表达谱的“衰老评分”方法,以检查与损伤相关或分泌性衰老的信号在各种人类肿瘤中持续存在的程度。结果我们首先显示,评分在一系列公共数据集中捕获了损伤或炎症途径的差异诱导,这些数据涉及结肠腺癌的放疗,乳腺癌细胞的化学疗法,间充质干细胞的复制衰老和黑色素瘤的进展。我们扩展了这些结果,以研究在NCI60面板中响应〜1500种化合物时衰老评分与生长抑制之间的相关性。我们自己的间充质肿瘤数据集的评分突显了MPNST,脂肪肉瘤和腹膜间皮瘤不同亚组之间分泌信号通路的差异表达。此外,分泌标记物的分层聚类产生的促炎信号在间皮瘤中显示出预后意义。结论我们发现“衰老评分”准确地报告了预期发生衰老的各种情况下的衰老信号,并以上下文相关的方式突出了损伤相关和分泌性衰老途径的差异表达。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号